Sartorius Aktiengesellschaft (SARTF)
Makes lab equipment and systems for biotech and pharmaceutical companies to develop and manufacture drugs.
$212.80+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+15.5%
The outlook
SARTF is trading near the middle of its 52-week range with a neutral analyst lean. The stock sits mixed relative to its moving averages, reflecting choppy recent momentum, while its trailing P/E of 66.3 signals a premium valuation relative to current earnings.
What’s behind the score
Price trendMixed vs its moving averages
52-week range69% of the way from its 52-week low to high
Market cap
$14.69B
52-wk high
$227.00
52-wk low
$181.58
50-day avg
$211.61
200-day avg
$218.11
Trailing P/E
66.3